As the population ages, diabetes prevalence among adults aged 65 and older is increasing, with about 16.5 million affected individuals in this age group, leading to a higher risk of diabetes-related complications. New treatments like Ozempic are improving diabetes management, with Medicare Part D covering it for Type 2 diabetes and reducing cardiovascular risk in those with Type 2 diabetes and known heart disease. Recent guidance from the Centers for Medicare and Medicaid Services allows Medicare Part D plans to cover Wegovy, a version of Ozempic approved for weight loss and heart health. Understanding Medicare coverage for medications like Ozempic is crucial, as it can vary based on plan formularies and eligibility criteria. Click here for article.
